Upadacitinib in Perianal Fistulizing CD; IBS Symptoms in IBD

The first study in The Regueiro Report this month assesses the efficacy and safety of upadacitinib for people with ...

AUGUST 14, 2025

The Global Evolution of IBD; Withdrawing Anti-TNF Therapy for IBD in Remission

This month's Regueiro Report looks at one of the most important papers about the epidemiology of IBD to appear for ...

JULY 17, 2025

White-Light Endoscopy for Cancer Detection, Capsule Endoscopy to Guide CD Treatment

This month, I focus on different endoscopic techniques that gastroenterologists might use, one for CRC detection in ...

JUNE 30, 2025

Risankizumab After Advanced Therapy for UC; GLP-1s for IBD

The first study in The Regueiro Report this month is a post hoc analysis of two successful phase 3 trials, INSPIRE ...

MAY 28, 2025

Cognitive Therapy for Fatigue, IBD Specialization and Treatment Decisions

The first study I highlight in The Regueiro Report this month focuses on how to reduce fatigue in people with ...

MARCH 20, 2025

Preventing Postoperative CD Recurrence and Predicting Recurrence Risk After Stopping Infliximab

One of my long-standing research interests is how to prevent CD recurrence after surgical resection.

FEBRUARY 21, 2025

Risankizumab and Tulisokibart for Ulcerative Colitis

We rarely discuss early trials, but this month we highlight a phase 2 trial that offers a promising new mechanism ...

JANUARY 23, 2025

Top-Down or Step-up Treatment For Newly Diagnosed CD, Standard or Intensified Infliximab Induction for ASUC

This month’s report examines two key studies on treatments for inflammatory bowel disease.

JANUARY 7, 2025

Upadacitinib Versus Tofacitinib in UC; Etrasimod for Proctitis

Prospective studies that directly compare the efficacy of two different medications remain rare in our field, ...

NOVEMBER 15, 2024

Head-to-Head IL Inhibitors, SPICY Trial Surgical Techniques in CD

In this edition of The Regueiro Report, I highlight a head-to-head comparison of two drugs and another study ...

OCTOBER 16, 2024

Treating Fibrostenosing Crohn’s and Optimizing Biologic Timing After Temporary Diversion Following Resection

This month’s The Regueiro Report focuses on best practices in two different scenarios of Crohn’s ...

AUGUST 16, 2024

Good News for Maintenance Therapies in IBD

Both studies in this month’s The Regueiro Report are about interleukin inhibitors: risankizumab and ...

JULY 16, 2024